1.43 USD
-0.010.00%
盘后 1.48 +3.50%
2026-08-03
市值
$6.15M
市盈率
—
EPS
-3.89
股息率
—
52 周区间
1.33 – 8.34
成交量
107.61K
Beta
-2.04
目标价
17.00
52W 低 1.3352W 高 8.34
价格走势
公司简介
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company’s lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant e...